A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0.005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension

Saved in:
Bibliographic Details
Published in:Clinical therapeutics 2006-03, Vol.28 (3), p.332-339
Main Authors: FRANKS, Wendy A, RENARD, Jean P, CUNLIFFE, Ian A, ROJANAPONGPUN, Prin
Format: Article
Language:English
Subjects:
Biological and medical sciences
Glaucoma and intraocular pressure
Medical sciences
Ophthalmology
Pharmacology. Drug treatments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 339
container_issue 3
container_start_page 332
container_title Clinical therapeutics
container_volume 28
creator FRANKS, Wendy A
RENARD, Jean P
CUNLIFFE, Ian A
ROJANAPONGPUN, Prin
description
doi_str_mv 10.1016/j.clinthera.2006.03.001
format article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_17747501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17747501</sourcerecordid><originalsourceid>FETCH-LOGICAL-p115t-1cbf7fb55f99cac5445c4d55991ee2733f0e781e09e5123fceb74f25ade631733</originalsourceid><addsrcrecordid>eNpNj0FrGzEQhUVpoW6S39C5-BZtNLsrr_cYQpsWAr20kFsYa0e2EllaJG2Df2X_UgTOoadheG--90aIr6gaVLi5eW6Md6EcOFHTKrVpVNcohR_ECrfDKBH7x49ipbAfZTvi9rP4kvOzUqobdbsS_25hI1-ZX65hisvOszxSfuHpGmZK5D17uU9xmSGXZTpBtFCTgK11hswJKEyQyXI5S4n-xjnFXEDVDv0aTDxWDk_w6soBPBUK_xn0-qa4Y_TR11WvwYWaWhyHks8Hc3JHSpU9c5AU9p5h72mpVIKYIJrFU4LDaeZUOGQXw6X4ZMlnvnqfF-LP92-_737Ih1_3P-9uH-SMqItEs7OD3Wltx7E-ovtem37SehyRuR26zioetshqZI1tZw3vht62mibedFj1C7E-c2fKhrxNFIzLT--Fn3AY-kEr7N4A6W2CIw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0.005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension</title><source>Elsevier</source><creator>FRANKS, Wendy A ; RENARD, Jean P ; CUNLIFFE, Ian A ; ROJANAPONGPUN, Prin</creator><creatorcontrib>FRANKS, Wendy A ; RENARD, Jean P ; CUNLIFFE, Ian A ; ROJANAPONGPUN, Prin</creatorcontrib><identifier>ISSN: 0149-2918</identifier><identifier>EISSN: 1879-114X</identifier><identifier>DOI: 10.1016/j.clinthera.2006.03.001</identifier><language>eng</language><publisher>Belle Mead, NJ: Excerpta Medica</publisher><subject>Biological and medical sciences ; Glaucoma and intraocular pressure ; Medical sciences ; Ophthalmology ; Pharmacology. Drug treatments</subject><ispartof>Clinical therapeutics, 2006-03, Vol.28 (3), p.332-339</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17747501$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>FRANKS, Wendy A</creatorcontrib><creatorcontrib>RENARD, Jean P</creatorcontrib><creatorcontrib>CUNLIFFE, Ian A</creatorcontrib><creatorcontrib>ROJANAPONGPUN, Prin</creatorcontrib><title>A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0.005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension</title><title>Clinical therapeutics</title><subject>Biological and medical sciences</subject><subject>Glaucoma and intraocular pressure</subject><subject>Medical sciences</subject><subject>Ophthalmology</subject><subject>Pharmacology. Drug treatments</subject><issn>0149-2918</issn><issn>1879-114X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpNj0FrGzEQhUVpoW6S39C5-BZtNLsrr_cYQpsWAr20kFsYa0e2EllaJG2Df2X_UgTOoadheG--90aIr6gaVLi5eW6Md6EcOFHTKrVpVNcohR_ECrfDKBH7x49ipbAfZTvi9rP4kvOzUqobdbsS_25hI1-ZX65hisvOszxSfuHpGmZK5D17uU9xmSGXZTpBtFCTgK11hswJKEyQyXI5S4n-xjnFXEDVDv0aTDxWDk_w6soBPBUK_xn0-qa4Y_TR11WvwYWaWhyHks8Hc3JHSpU9c5AU9p5h72mpVIKYIJrFU4LDaeZUOGQXw6X4ZMlnvnqfF-LP92-_737Ih1_3P-9uH-SMqItEs7OD3Wltx7E-ovtem37SehyRuR26zioetshqZI1tZw3vht62mibedFj1C7E-c2fKhrxNFIzLT--Fn3AY-kEr7N4A6W2CIw</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>FRANKS, Wendy A</creator><creator>RENARD, Jean P</creator><creator>CUNLIFFE, Ian A</creator><creator>ROJANAPONGPUN, Prin</creator><general>Excerpta Medica</general><scope>IQODW</scope></search><sort><creationdate>20060301</creationdate><title>A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0.005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension</title><author>FRANKS, Wendy A ; RENARD, Jean P ; CUNLIFFE, Ian A ; ROJANAPONGPUN, Prin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p115t-1cbf7fb55f99cac5445c4d55991ee2733f0e781e09e5123fceb74f25ade631733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biological and medical sciences</topic><topic>Glaucoma and intraocular pressure</topic><topic>Medical sciences</topic><topic>Ophthalmology</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FRANKS, Wendy A</creatorcontrib><creatorcontrib>RENARD, Jean P</creatorcontrib><creatorcontrib>CUNLIFFE, Ian A</creatorcontrib><creatorcontrib>ROJANAPONGPUN, Prin</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Clinical therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FRANKS, Wendy A</au><au>RENARD, Jean P</au><au>CUNLIFFE, Ian A</au><au>ROJANAPONGPUN, Prin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0.005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension</atitle><jtitle>Clinical therapeutics</jtitle><date>2006-03-01</date><risdate>2006</risdate><volume>28</volume><issue>3</issue><spage>332</spage><epage>339</epage><pages>332-339</pages><issn>0149-2918</issn><eissn>1879-114X</eissn><cop>Belle Mead, NJ</cop><pub>Excerpta Medica</pub><doi>10.1016/j.clinthera.2006.03.001</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0149-2918
ispartof Clinical therapeutics, 2006-03, Vol.28 (3), p.332-339
issn 0149-2918
1879-114X
language eng
recordid cdi_pascalfrancis_primary_17747501
source Elsevier
subjects Biological and medical sciences
Glaucoma and intraocular pressure
Medical sciences
Ophthalmology
Pharmacology. Drug treatments
title A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0.005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T02%3A20%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%206-week,%20double-masked,%20parallel-group%20study%20of%20the%20efficacy%20and%20safety%20of%20travoprost%200.004%25%20compared%20with%20latanoprost%200.005%25/timolol%200.5%25%20in%20patients%20with%20primary%20open-angle%20glaucoma%20or%20ocular%20hypertension&rft.jtitle=Clinical%20therapeutics&rft.au=FRANKS,%20Wendy%20A&rft.date=2006-03-01&rft.volume=28&rft.issue=3&rft.spage=332&rft.epage=339&rft.pages=332-339&rft.issn=0149-2918&rft.eissn=1879-114X&rft_id=info:doi/10.1016/j.clinthera.2006.03.001&rft_dat=%3Cpascalfrancis%3E17747501%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p115t-1cbf7fb55f99cac5445c4d55991ee2733f0e781e09e5123fceb74f25ade631733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true